Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada
Ramandip Grewal, Sarah A Buchan, Lena Nguyen, View ORCID ProfileSharifa Nasreen, Peter C. Austin, Kevin A. Brown, Jonathan Gubbay, Nelson Lee, Kevin L Schwartz, Mina Tadrous, Kumanan Wilson, Sarah E Wilson, Jeffrey C Kwong the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators
doi: https://doi.org/10.1101/2023.04.11.23288403
Ramandip Grewal
1Public Health Ontario, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
Sarah A Buchan
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
Lena Nguyen
2ICES, Toronto, Ontario, Canada
Sharifa Nasreen
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Peter C. Austin
2ICES, Toronto, Ontario, Canada
5Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Kevin A. Brown
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Jonathan Gubbay
1Public Health Ontario, Toronto, Ontario, Canada
7British Columbia Children’s Hospital, Vancouver, British Columbia, Canada
Nelson Lee
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Kevin L Schwartz
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Mina Tadrous
2ICES, Toronto, Ontario, Canada
8Women’s College Hospital, Toronto, ON, Canada
9Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Kumanan Wilson
10Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
11Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
12Bruyere Research Institute, Ottawa, Ontario, Canada
Sarah E Wilson
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
Jeffrey C Kwong
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
13Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
14University Health Network, Toronto, Ontario, Canada
Data Availability
The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet prespecified criteria for confidential access, available at www.ices.on.ca/DAS (email: das{at}ices.on.ca). The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification.
Posted April 11, 2023.
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada
Ramandip Grewal, Sarah A Buchan, Lena Nguyen, Sharifa Nasreen, Peter C. Austin, Kevin A. Brown, Jonathan Gubbay, Nelson Lee, Kevin L Schwartz, Mina Tadrous, Kumanan Wilson, Sarah E Wilson, Jeffrey C Kwong
medRxiv 2023.04.11.23288403; doi: https://doi.org/10.1101/2023.04.11.23288403
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada
Ramandip Grewal, Sarah A Buchan, Lena Nguyen, Sharifa Nasreen, Peter C. Austin, Kevin A. Brown, Jonathan Gubbay, Nelson Lee, Kevin L Schwartz, Mina Tadrous, Kumanan Wilson, Sarah E Wilson, Jeffrey C Kwong
medRxiv 2023.04.11.23288403; doi: https://doi.org/10.1101/2023.04.11.23288403
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12629)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2873)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2229)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)